| Extreme genetic risk for type 1A diabetes TA Aly, A Ide, MM Jahromi, JM Barker, MS Fernando, SR Babu, L Yu, ... Proceedings of the National Academy of Sciences 103 (38), 14074-14079, 2006 | 312 | 2006 |
| Cellular and molecular pathogenesis of type 1A diabetes MM Jahromi, GS Eisenbarth Cellular and molecular life sciences 64, 865-872, 2007 | 146 | 2007 |
| A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus MM Jahromi, BA Millward, AG Demaine Journal of interferon & cytokine research 20 (10), 885-888, 2000 | 141 | 2000 |
| A CA Repeat Polymorphism of the IFN-gamma Gene Is Associated with Susceptibility to Type 1 Diabetes M Jahromi, A Millward, A Demaine Journal of interferon & cytokine research 20 (2), 187-190, 2000 | 105 | 2000 |
| Genetic determinants of type 1 diabetes across populations MM Jahromi, GS Eisenbarth Annals of the New York Academy of Sciences 1079 (1), 289-299, 2006 | 77 | 2006 |
| Analysis of single nucleotide polymorphisms identifies major type 1A diabetes locus telomeric of the major histocompatibility complex TA Aly, EE Baschal, MM Jahromi, MS Fernando, SR Babu, TE Fingerlin, ... Diabetes 57 (3), 770-776, 2008 | 61 | 2008 |
| A STUDY OF CYTOKINE PROTEIN SECRETION, FREQUENCIES OF CYTOKINE EXPRESSING CELLS AND IFN-G GENE POLYMORPHISMS IN NORMAL INDIVIDUALS1 N Cartwright, A Demaine, M Jahromi, H Sanders, ER Kaminski Transplantation 68 (10), 1546-1552, 1999 | 50 | 1999 |
| Type 1 diabetes: chronic progressive autoimmune disease L Zhang, R Gianani, M Nakayama, E Liu, M Kobayashi, E Baschal, L Yu, ... Defining Optimal Immunotherapies for Type 1 Diabetes: Novartis Foundation …, 2008 | 39 | 2008 |
| Partial protection of Sinopharm vaccine against SARS COV2 during recent outbreak in Bahrain M Jahromi, MH Al Sheikh Microbial Pathogenesis 158, 105086, 2021 | 36 | 2021 |
| Distribution of hepatitis C virus genotypes in Bahrain EM Janahi, M Al-Mannai, H Singh, MM Jahromi Hepatitis monthly 15 (12), 2015 | 22 | 2015 |
| Haplotype specific alteration of diabetes MHC risk by olfactory receptor gene polymorphism MM Jahromi Autoimmunity reviews 12 (2), 270-274, 2012 | 20 | 2012 |
| Significant correlation between association of polymorphism in codon 10 of transforming growth factor-β1 T (29) C with type 1 diabetes and patients with nephropathy disorder MM Jahromi, BA Millward, AG Demaine Journal of Interferon & Cytokine Research 30 (2), 59-66, 2010 | 20 | 2010 |
| Diabetic foot ulcer outcomes from a podiatry led tertiary service in Kuwait G Messenger, R Masoetsa, I Hussain, S Devarajan, M Jahromi Diabetic foot & ankle 9 (1), 1471927, 2018 | 16 | 2018 |
| Human leukocyte antigen (HLA) and islet autoantibodies are tools to characterize type 1 diabetes in Arab countries: emphasis on Kuwait M Jahromi, E Al-Ozairi Disease Markers 2019, 2019 | 14 | 2019 |
| Immunogenetics of Celiac Disease: A focus on Arab countries N Younes, S Younes, O Alsharabasi, ME El Zowalaty, I Mustafa, ... Current molecular medicine 20 (4), 275-285, 2020 | 9 | 2020 |
| Prevalence of nephropathy in type 1 diabetes in the Arab world: A systematic review and meta‐analysis UM Abdel‐Motal, EM Abdelalim, C Ponnuraja, K Iken, M Jahromi, ... Diabetes/Metabolism Research and Reviews 34 (7), e3026, 2018 | 9 | 2018 |
| Immunogenetics of new onset diabetes after transplantation in Kuwait M Jahromi, T Al-Otaibi, N Othman, O Gheith, T Mahmoud, P Nair, ... Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 731-742, 2019 | 6 | 2019 |
| Critical association study of olfactory receptor Gene polymorphism in diabetic complications M Jahromi, A Ahmed, K Behbehani, A Mohammad Immunome Research 10 (2), 1, 2014 | 6 | 2014 |
| Detection of the HLA‐DRB4* 01: 44 allele in a Kuwaiti individual. M Jahromi, Z Rahma, N Taha, PY Lin, KL Yang HLA: Immune Response Genetics 96 (4), 2020 | 4 | 2020 |
| Recent expeditious growth of type 1 diabetes in the Gulf Arab Countries M Jahromi, M Al Sheikh, J Tuomilehto Preprints, 2021 | 3 | 2021 |
